Nissan Chemical Corporation
Stock Price Chart
2026/03/02 UpdatedPrice Trend
2026/03/02 UpdatedPrice & Trading Details
2026/03/02 UpdatedPRICE
TRADING
Analyst Recommendations 9 analysts
Updated 2026/03/01Shareholder Composition
Updated 2026/03/01Top Mutual Funds / ETFs
Updated 2026/03/01Major Holders
Updated 2026/03/01| Fund Name | Ownership | Shares | Change |
|---|---|---|---|
|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
|
1.8M | +0.93% | |
|
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
|
1.1M | +3.01% | |
|
iShares Trust-iShares Core MSCI EAFE ETF
|
880.1K | 0.00% | |
|
Fidelity Investment Trust-Fidelity Diversified International Fund
|
770.1K | 0.00% | |
|
Victory Portfolios-Victory Trivalent International Small-Cap Fund
|
492.9K | +1.00% | |
|
iShares Trust-iShares MSCI EAFE Small-Cap ETF
|
458.2K | 0.00% |
| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
Pacer Advisors, Inc.
|
20 | +1.00% |
Dividend History 1Years Growth
Updated 2026/03/01| Year | Dividend | Change |
|---|---|---|
| 2025 | ¥174 | +6.1% |
| 2024 | ¥164 | 0.0% |
| 2023 | ¥164 | +15.5% |
| 2022 | ¥142 | +39.2% |
| 2021 | ¥102 | - |
Financial Performance
2026/03/01 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥207,972M | ¥228,065M | ¥226,705M | ¥251,365M |
| Gross Profit | ¥101,089M | ¥106,803M | ¥104,774M | ¥116,541M |
| Operating Income | ¥50,960M | ¥52,284M | ¥48,202M | ¥56,833M |
| Pretax Income | ¥54,233M | ¥56,857M | ¥52,311M | ¥60,124M |
| Net Income | ¥38,776M | ¥41,087M | ¥38,033M | ¥43,043M |
| EPS | ¥271.88 | ¥291.36 | ¥272.82 | ¥313.26 |
| Operating Margin | 24.50% | 22.93% | 21.26% | 22.61% |
| Balance Sheet | ||||
| Total Assets | ¥279,687M | ¥298,715M | ¥323,458M | ¥330,763M |
| Total Equity | ¥205,910M | ¥218,418M | ¥227,519M | ¥233,290M |
| Total Liabilities | ¥73,777M | ¥80,297M | ¥95,939M | ¥97,473M |
| Cash | ¥34,658M | ¥29,647M | ¥22,738M | ¥27,454M |
| Interest-bearing Debt | ¥22,715M | ¥27,289M | ¥40,980M | ¥40,474M |
| Equity Ratio | 73.62% | 73.12% | 70.34% | 70.53% |
| D/E Ratio | 0.11 | 0.12 | 0.18 | 0.17 |
| Cash Flow | ||||
| Operating CF | ¥41,949M | ¥35,226M | ¥33,701M | ¥59,178M |
| Investing CF | -¥12,395M | -¥19,643M | -¥18,741M | -¥17,612M |
| Financing CF | -¥27,868M | -¥25,030M | -¥22,101M | -¥35,650M |
| Free CF | ¥29,097M | ¥15,053M | ¥12,703M | ¥40,810M |
| Efficiency | ||||
| ROE | 18.83% | 18.81% | 16.72% | 18.45% |
| ROA | 13.86% | 13.75% | 11.76% | 13.01% |
Latest IR Information
-
Correction) Notice Regarding Executive Personnel Changes
Announced correction regarding executive personnel related to the Audit & Supervisory Board members as of June 25, 2026. Corrections were made to the position titles of Kazuhiko Orai and Kazuhiko Orai.
Read more -
Notice Regarding Cancellation of Treasury Stock (Cancellation of Treasury Stock Based on the Provisions of Article 178 of the Companies Act)
Nissan Chemical Corporation resolved to cancel 1,000,000 shares of treasury stock (0.74% of total shares issued before cancellation) on March 12, 2026.
Read more -
Notice Regarding Executive Personnel Changes
Announced executive and key personnel changes effective April 1, 2026, and June 25, 2026. Changes include reassignments of directors, executive officers, and board members, as well as establishment of new departments.
Read more -
Consolidated Financial Summary for the Third Quarter of Fiscal Year Ending March 2026 [Japanese GAAP]
For the third quarter of the fiscal year ending March 2026, net sales were JPY 195.435 billion (up 11.8% YoY), operating income was JPY 44.984 billion (up 9.5% YoY), and quarterly net income attributable to owners of the parent was...
Read more -
FY2026 March Q3 Financial Results Briefing
For Q3 FY2025, net sales were 195.4 billion yen (12% YoY increase), operating income was 45.0 billion yen (10% YoY increase), and net income was 35.0 billion yen (11% YoY increase), with no revisions to the full-year earnings forecast.
Read more
Latest News (5 items)
-
Average Analyst Rating: buy
Average Target Price: ¥6,180
Rating Score: 1.89 (Based on 9 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
Nissan Chemical Corporation engages in the chemicals, performance materials, agricultural chemicals, and pharmaceuticals businesses in Japan and internationally. The company provides high purity and custom chemicals; AdBlue, an urea solution; ammonia, sulfuric, and nitric acid, as well as concrete products; TEPIC, an epoxy compound; Melamine Cyanurate, a salt of melamine and iso cyanuric acid; TEPIC-VL, a liquid epoxy compound; Nissan Reishi, a health food; phenylphosphonic acid; HI-LITE, a chlorinated isocyanulate; FINEOXOCOL, a saturated fatty alcohol and acid; HARDBEADS, a spherical fine particles; STARFINE, a Triazine based adhesion; melamine polyphosphate; and NFG, a highly functional additive. It also offers performance materials comprising display, semiconductor, and inorganic materials; agricultural chemicals, such as herbicides, insecticides, fungicides, etc. for use on agricultural land, as well as in golf courses and parks; and drug substances for antiparasite drugs for animals. In addition, the company provides pharmaceutical products, such as LIVALO, a antihypercholesterolemic agent; LANDEL and FINTE, a long-acting calcium channel blocker; and APIs and intermediaries, as well as develops NTC-801, a pharmacological therapeutic agent for treatment of arrhythmia. Further, it develops healthcare, information and communication, and energy materials. The company was formerly known as Nissan Chemical Industries, Ltd. and changed its name to Nissan Chemical Corporation in July 2018. Nissan Chemical Corporation was founded in 1887 and is headquartered in Tokyo, Japan.